I am honoured to share my testimony on the transformative impact of CELOX™ PPH at Charite Hospital, Berlin. Over the past 12+ years, CELOX™ PPH has emerged as a remarkable treatment option for postpartum haemorrhage (PPH). Notably, we have witnessed a substantial reduction in hysterectomy rates following its implementation. In my professional opinion, CELOX™ PPH surpasses balloon tamponade in both effectiveness and application due to the haemostatic chitosan agent. Furthermore, its early utilisation in high-risk bleeding cases is well-justified